The ADAP STAR assay ready workstation is the instrument of choice for the accurate detection of SARS-CoV-2, only days after infection, using the ultrasensitive quantitative Antibody Detection by Agglutination PCR (ADAP) technology by Enable Biosciences. Critically important prevalence testing within the general population is made possible with throughputs of up to 96 samples at a time. All peripheral devices, like a plate sealer, on-deck thermal cycler, and cold plate air-cooled device, are included to maximize walkaway time and minimize operator exposure to potential biohazards.